|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Change in fair value in derivative liability | |||||
| Non-cash lease adjustment | |||||
| Provision for credit losses | |||||
| Inventory write-down | |||||
| (Gain) loss on foreign currency transactions | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued interest expense | |||||
| Loan facility liability | |||||
| Deferred revenue | |||||
| Reimbursements for leasehold improvements from operating leases | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Proceeds from issuance of common stock from the exercise of stock options, net | |||||
| Proceeds from issuance of common stock from the initial public offering, net of underwriting discounts, commissions and offering expenses | |||||
| Proceeds from issuance of common stock, net of issuance costs | |||||
| Proceeds from the exercise of redeemable convertible preferred stock warrants | |||||
| Proceeds from issuance of Series G redeemable convertible preferred stock, net of issuance costs | |||||
| Series G | |||||
| Proceeds from issuance of long-term debt, net of issuance costs | |||||
| Payment of principal on long-term debt | |||||
| Payment of final payment fee | |||||
| Payment of prepayment fee | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rates on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Beginning of the period | |||||
| End of the period | |||||
| Supplemental cash flow information | |||||
| Interest paid | |||||
| Non-cash investing and financing activities | |||||
| Transfer of evaluation units from inventory to property and equipment, net | |||||
| Property and equipment included in accounts payable and accrued expenses | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Conversion of redeemable convertible preferred stock to common stock | |||||
| Reconciliation of cash, cash equivalents and restricted cash to balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...